A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Clinical trial NCT05611801 · RECRUITING

Trial details

NCT number: NCT05611801
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hemophilia A Hemophilia B

Start date: 2022-12-09
Primary completion: 2028-09-10
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.